KYMERA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.02 USD | -1.52% |
|
+2.01% | +49.84% |
| 03/05 | Oppenheimer Adjusts Kymera Therapeutics Price Target to $52 From $53 | MT |
| 02/05 | Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 40.20 | 43.57 | 43.50 |
| Spread/Res. | -5.10% | -12.44% | -12.30% |
| Spread/Supp. | +14.39% | +55.71% | +69.03% |
| Support | 33.35 | 24.50 | 22.57 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- KYMR Stock
- Charts Kymera Therapeutics, Inc.